nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—kidney cancer	0.271	1	CbGaD
Levetiracetam—ABCC2—Paclitaxel—kidney cancer	0.0566	0.11	CbGbCtD
Levetiracetam—ABCB1—Temsirolimus—kidney cancer	0.0538	0.104	CbGbCtD
Levetiracetam—ABCC2—Sorafenib—kidney cancer	0.0503	0.0976	CbGbCtD
Levetiracetam—ABCC2—Vinblastine—kidney cancer	0.0497	0.0964	CbGbCtD
Levetiracetam—ABCC2—Vincristine—kidney cancer	0.0488	0.0947	CbGbCtD
Levetiracetam—ABCC2—Sunitinib—kidney cancer	0.0408	0.0791	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—kidney cancer	0.0305	0.0592	CbGbCtD
Levetiracetam—ABCB1—Pazopanib—kidney cancer	0.0283	0.0548	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—kidney cancer	0.0259	0.0501	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—kidney cancer	0.0204	0.0396	CbGbCtD
Levetiracetam—ABCB1—Erlotinib—kidney cancer	0.0202	0.0391	CbGbCtD
Levetiracetam—ABCB1—Paclitaxel—kidney cancer	0.0185	0.0358	CbGbCtD
Levetiracetam—ABCB1—Sorafenib—kidney cancer	0.0164	0.0318	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—kidney cancer	0.0162	0.0314	CbGbCtD
Levetiracetam—ABCB1—Vincristine—kidney cancer	0.0159	0.0309	CbGbCtD
Levetiracetam—ABCB1—Sunitinib—kidney cancer	0.0133	0.0258	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—kidney cancer	0.00995	0.0193	CbGbCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—RYR1—kidney cancer	0.000241	0.0799	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—GJB1—kidney cancer	0.000159	0.0529	CbGpPWpGaD
Levetiracetam—ABCC2—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000155	0.0514	CbGpPWpGaD
Levetiracetam—ABCC2—Irinotecan Pathway—BCHE—kidney cancer	0.000131	0.0436	CbGpPWpGaD
Levetiracetam—Agitation—Paclitaxel—kidney cancer	0.000119	0.000566	CcSEcCtD
Levetiracetam—Rash—Everolimus—kidney cancer	0.000119	0.000565	CcSEcCtD
Levetiracetam—Dermatitis—Everolimus—kidney cancer	0.000119	0.000565	CcSEcCtD
Levetiracetam—Headache—Vinblastine—kidney cancer	0.000119	0.000564	CcSEcCtD
Levetiracetam—Headache—Everolimus—kidney cancer	0.000118	0.000561	CcSEcCtD
Levetiracetam—Body temperature increased—Dactinomycin—kidney cancer	0.000118	0.00056	CcSEcCtD
Levetiracetam—Abdominal pain—Dactinomycin—kidney cancer	0.000118	0.00056	CcSEcCtD
Levetiracetam—Asthenia—Sorafenib—kidney cancer	0.000117	0.000558	CcSEcCtD
Levetiracetam—Vertigo—Paclitaxel—kidney cancer	0.000116	0.000554	CcSEcCtD
Levetiracetam—Lethargy—Doxorubicin—kidney cancer	0.000116	0.000552	CcSEcCtD
Levetiracetam—Leukopenia—Paclitaxel—kidney cancer	0.000116	0.000552	CcSEcCtD
Levetiracetam—Hypersensitivity—Sunitinib—kidney cancer	0.000116	0.000552	CcSEcCtD
Levetiracetam—Decreased appetite—Vincristine—kidney cancer	0.000116	0.00055	CcSEcCtD
Levetiracetam—Pruritus—Sorafenib—kidney cancer	0.000116	0.00055	CcSEcCtD
Levetiracetam—Vomiting—Erlotinib—kidney cancer	0.000116	0.00055	CcSEcCtD
Levetiracetam—Erythema multiforme—Capecitabine—kidney cancer	0.000116	0.000549	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000115	0.000547	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vincristine—kidney cancer	0.000115	0.000547	CcSEcCtD
Levetiracetam—Fatigue—Vincristine—kidney cancer	0.000115	0.000546	CcSEcCtD
Levetiracetam—Rash—Erlotinib—kidney cancer	0.000115	0.000545	CcSEcCtD
Levetiracetam—Dermatitis—Erlotinib—kidney cancer	0.000115	0.000545	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—kidney cancer	0.000114	0.000543	CcSEcCtD
Levetiracetam—Insomnia—Gemcitabine—kidney cancer	0.000114	0.000543	CcSEcCtD
Levetiracetam—Eye disorder—Capecitabine—kidney cancer	0.000114	0.000543	CcSEcCtD
Levetiracetam—Headache—Erlotinib—kidney cancer	0.000114	0.000542	CcSEcCtD
Levetiracetam—Constipation—Vincristine—kidney cancer	0.000114	0.000541	CcSEcCtD
Levetiracetam—Pain—Vincristine—kidney cancer	0.000114	0.000541	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—kidney cancer	0.000114	0.000541	CcSEcCtD
Levetiracetam—Paraesthesia—Gemcitabine—kidney cancer	0.000113	0.000539	CcSEcCtD
Levetiracetam—Cough—Paclitaxel—kidney cancer	0.000113	0.000538	CcSEcCtD
Levetiracetam—Asthenia—Sunitinib—kidney cancer	0.000113	0.000537	CcSEcCtD
Levetiracetam—Nausea—Vinblastine—kidney cancer	0.000112	0.000534	CcSEcCtD
Levetiracetam—Somnolence—Gemcitabine—kidney cancer	0.000112	0.000534	CcSEcCtD
Levetiracetam—Convulsion—Paclitaxel—kidney cancer	0.000112	0.000534	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—kidney cancer	0.000112	0.000533	CcSEcCtD
Levetiracetam—Nausea—Everolimus—kidney cancer	0.000112	0.000532	CcSEcCtD
Levetiracetam—Diarrhoea—Sorafenib—kidney cancer	0.000112	0.000532	CcSEcCtD
Levetiracetam—Pruritus—Sunitinib—kidney cancer	0.000111	0.00053	CcSEcCtD
Levetiracetam—Immune system disorder—Capecitabine—kidney cancer	0.00011	0.000525	CcSEcCtD
Levetiracetam—Chest pain—Paclitaxel—kidney cancer	0.00011	0.000525	CcSEcCtD
Levetiracetam—Arthralgia—Paclitaxel—kidney cancer	0.00011	0.000525	CcSEcCtD
Levetiracetam—Myalgia—Paclitaxel—kidney cancer	0.00011	0.000525	CcSEcCtD
Levetiracetam—Mediastinal disorder—Capecitabine—kidney cancer	0.00011	0.000524	CcSEcCtD
Levetiracetam—Anxiety—Paclitaxel—kidney cancer	0.00011	0.000523	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—kidney cancer	0.00011	0.000523	CcSEcCtD
Levetiracetam—Decreased appetite—Gemcitabine—kidney cancer	0.00011	0.000522	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—kidney cancer	0.00011	0.000522	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00011	0.000521	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000109	0.000519	CcSEcCtD
Levetiracetam—Fatigue—Gemcitabine—kidney cancer	0.000109	0.000518	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—kidney cancer	0.000109	0.000518	CcSEcCtD
Levetiracetam—Dizziness—Sorafenib—kidney cancer	0.000108	0.000514	CcSEcCtD
Levetiracetam—Pain—Gemcitabine—kidney cancer	0.000108	0.000514	CcSEcCtD
Levetiracetam—Constipation—Gemcitabine—kidney cancer	0.000108	0.000514	CcSEcCtD
Levetiracetam—Nausea—Erlotinib—kidney cancer	0.000108	0.000514	CcSEcCtD
Levetiracetam—Alopecia—Capecitabine—kidney cancer	0.000108	0.000513	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—kidney cancer	0.000108	0.000513	CcSEcCtD
Levetiracetam—Diarrhoea—Sunitinib—kidney cancer	0.000108	0.000512	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—kidney cancer	0.000107	0.000509	CcSEcCtD
Levetiracetam—Mental disorder—Capecitabine—kidney cancer	0.000107	0.000509	CcSEcCtD
Levetiracetam—Asthenia—Dactinomycin—kidney cancer	0.000107	0.000508	CcSEcCtD
Levetiracetam—Confusional state—Paclitaxel—kidney cancer	0.000107	0.000507	CcSEcCtD
Levetiracetam—Malnutrition—Capecitabine—kidney cancer	0.000106	0.000506	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—kidney cancer	0.000106	0.000503	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—kidney cancer	0.000105	0.000501	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—kidney cancer	0.000105	0.000501	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—kidney cancer	0.000105	0.0005	CcSEcCtD
Levetiracetam—Infection—Paclitaxel—kidney cancer	0.000105	0.0005	CcSEcCtD
Levetiracetam—Dizziness—Sunitinib—kidney cancer	0.000104	0.000495	CcSEcCtD
Levetiracetam—Feeling abnormal—Gemcitabine—kidney cancer	0.000104	0.000495	CcSEcCtD
Levetiracetam—Vomiting—Sorafenib—kidney cancer	0.000104	0.000495	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—kidney cancer	0.000104	0.000494	CcSEcCtD
Levetiracetam—Nervous system disorder—Paclitaxel—kidney cancer	0.000104	0.000493	CcSEcCtD
Levetiracetam—Thrombocytopenia—Paclitaxel—kidney cancer	0.000104	0.000492	CcSEcCtD
Levetiracetam—Rash—Sorafenib—kidney cancer	0.000103	0.00049	CcSEcCtD
Levetiracetam—Dermatitis—Sorafenib—kidney cancer	0.000103	0.00049	CcSEcCtD
Levetiracetam—Back pain—Capecitabine—kidney cancer	0.000103	0.000489	CcSEcCtD
Levetiracetam—Skin disorder—Paclitaxel—kidney cancer	0.000103	0.000488	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000103	0.000487	CcSEcCtD
Levetiracetam—Headache—Sorafenib—kidney cancer	0.000103	0.000487	CcSEcCtD
Levetiracetam—Diarrhoea—Dactinomycin—kidney cancer	0.000102	0.000485	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—kidney cancer	0.000102	0.000484	CcSEcCtD
Levetiracetam—Anorexia—Paclitaxel—kidney cancer	0.000101	0.000479	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—kidney cancer	0.0001	0.000477	CcSEcCtD
Levetiracetam—Vision blurred—Capecitabine—kidney cancer	0.0001	0.000477	CcSEcCtD
Levetiracetam—Vomiting—Sunitinib—kidney cancer	0.0001	0.000476	CcSEcCtD
Levetiracetam—Body temperature increased—Gemcitabine—kidney cancer	9.99e-05	0.000475	CcSEcCtD
Levetiracetam—Tremor—Capecitabine—kidney cancer	9.97e-05	0.000474	CcSEcCtD
Levetiracetam—Rash—Sunitinib—kidney cancer	9.93e-05	0.000472	CcSEcCtD
Levetiracetam—Dermatitis—Sunitinib—kidney cancer	9.92e-05	0.000472	CcSEcCtD
Levetiracetam—Headache—Sunitinib—kidney cancer	9.87e-05	0.000469	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—kidney cancer	9.84e-05	0.000468	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—kidney cancer	9.84e-05	0.000468	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—kidney cancer	9.82e-05	0.000466	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—kidney cancer	9.75e-05	0.000463	CcSEcCtD
Levetiracetam—Nausea—Sorafenib—kidney cancer	9.72e-05	0.000462	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—kidney cancer	9.65e-05	0.000459	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.64e-05	0.000458	CcSEcCtD
Levetiracetam—Insomnia—Paclitaxel—kidney cancer	9.57e-05	0.000455	CcSEcCtD
Levetiracetam—Vertigo—Capecitabine—kidney cancer	9.56e-05	0.000454	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—kidney cancer	9.56e-05	0.000454	CcSEcCtD
Levetiracetam—Leukopenia—Capecitabine—kidney cancer	9.52e-05	0.000453	CcSEcCtD
Levetiracetam—Paraesthesia—Paclitaxel—kidney cancer	9.5e-05	0.000452	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—kidney cancer	9.48e-05	0.000451	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—kidney cancer	9.47e-05	0.00045	CcSEcCtD
Levetiracetam—Somnolence—Paclitaxel—kidney cancer	9.41e-05	0.000447	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—kidney cancer	9.4e-05	0.000447	CcSEcCtD
Levetiracetam—Nausea—Sunitinib—kidney cancer	9.36e-05	0.000445	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—kidney cancer	9.35e-05	0.000444	CcSEcCtD
Levetiracetam—Dyspepsia—Paclitaxel—kidney cancer	9.32e-05	0.000443	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	9.29e-05	0.0308	CbGpPWpGaD
Levetiracetam—Cough—Capecitabine—kidney cancer	9.29e-05	0.000441	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—kidney cancer	9.2e-05	0.000437	CcSEcCtD
Levetiracetam—Decreased appetite—Paclitaxel—kidney cancer	9.2e-05	0.000437	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.15e-05	0.000435	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.14e-05	0.000434	CcSEcCtD
Levetiracetam—Fatigue—Paclitaxel—kidney cancer	9.12e-05	0.000434	CcSEcCtD
Levetiracetam—Diarrhoea—Vincristine—kidney cancer	9.12e-05	0.000433	CcSEcCtD
Levetiracetam—Asthenia—Gemcitabine—kidney cancer	9.07e-05	0.000431	CcSEcCtD
Levetiracetam—Chest pain—Capecitabine—kidney cancer	9.06e-05	0.00043	CcSEcCtD
Levetiracetam—Myalgia—Capecitabine—kidney cancer	9.06e-05	0.00043	CcSEcCtD
Levetiracetam—Arthralgia—Capecitabine—kidney cancer	9.06e-05	0.00043	CcSEcCtD
Levetiracetam—Pain—Paclitaxel—kidney cancer	9.05e-05	0.00043	CcSEcCtD
Levetiracetam—Constipation—Paclitaxel—kidney cancer	9.05e-05	0.00043	CcSEcCtD
Levetiracetam—Anxiety—Capecitabine—kidney cancer	9.03e-05	0.000429	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9e-05	0.000428	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—kidney cancer	8.96e-05	0.000426	CcSEcCtD
Levetiracetam—Pruritus—Gemcitabine—kidney cancer	8.94e-05	0.000425	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—kidney cancer	8.91e-05	0.000423	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—kidney cancer	8.86e-05	0.000421	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—kidney cancer	8.81e-05	0.000419	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—kidney cancer	8.78e-05	0.000417	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—kidney cancer	8.78e-05	0.000417	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—kidney cancer	8.78e-05	0.000417	CcSEcCtD
Levetiracetam—Confusional state—Capecitabine—kidney cancer	8.76e-05	0.000416	CcSEcCtD
Levetiracetam—Feeling abnormal—Paclitaxel—kidney cancer	8.72e-05	0.000414	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.7e-05	0.000414	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Paclitaxel—kidney cancer	8.65e-05	0.000411	CcSEcCtD
Levetiracetam—Diarrhoea—Gemcitabine—kidney cancer	8.65e-05	0.000411	CcSEcCtD
Levetiracetam—Infection—Capecitabine—kidney cancer	8.63e-05	0.00041	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—kidney cancer	8.56e-05	0.000407	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—kidney cancer	8.53e-05	0.000405	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—kidney cancer	8.53e-05	0.000405	CcSEcCtD
Levetiracetam—Nervous system disorder—Capecitabine—kidney cancer	8.52e-05	0.000405	CcSEcCtD
Levetiracetam—Thrombocytopenia—Capecitabine—kidney cancer	8.5e-05	0.000404	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—kidney cancer	8.47e-05	0.000403	CcSEcCtD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	8.47e-05	0.0281	CbGpPWpGaD
Levetiracetam—Skin disorder—Capecitabine—kidney cancer	8.44e-05	0.000401	CcSEcCtD
Levetiracetam—Rash—Vincristine—kidney cancer	8.4e-05	0.000399	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—kidney cancer	8.39e-05	0.000399	CcSEcCtD
Levetiracetam—Abdominal pain—Paclitaxel—kidney cancer	8.37e-05	0.000398	CcSEcCtD
Levetiracetam—Body temperature increased—Paclitaxel—kidney cancer	8.37e-05	0.000398	CcSEcCtD
Levetiracetam—Headache—Vincristine—kidney cancer	8.35e-05	0.000397	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—kidney cancer	8.3e-05	0.000394	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—kidney cancer	8.28e-05	0.000393	CcSEcCtD
Levetiracetam—Anorexia—Capecitabine—kidney cancer	8.28e-05	0.000393	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—kidney cancer	8.23e-05	0.000391	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—kidney cancer	8.19e-05	0.000389	CcSEcCtD
Levetiracetam—Vomiting—Gemcitabine—kidney cancer	8.04e-05	0.000382	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—kidney cancer	7.97e-05	0.000379	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—kidney cancer	7.96e-05	0.000378	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—kidney cancer	7.92e-05	0.000376	CcSEcCtD
Levetiracetam—Nausea—Vincristine—kidney cancer	7.91e-05	0.000376	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.91e-05	0.000376	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—kidney cancer	7.9e-05	0.000375	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—kidney cancer	7.88e-05	0.000374	CcSEcCtD
Levetiracetam—Insomnia—Capecitabine—kidney cancer	7.85e-05	0.000373	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—kidney cancer	7.82e-05	0.000372	CcSEcCtD
Levetiracetam—Paraesthesia—Capecitabine—kidney cancer	7.8e-05	0.000371	CcSEcCtD
Levetiracetam—Hypersensitivity—Paclitaxel—kidney cancer	7.8e-05	0.000371	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—kidney cancer	7.74e-05	0.000368	CcSEcCtD
Levetiracetam—Dyspepsia—Capecitabine—kidney cancer	7.64e-05	0.000363	CcSEcCtD
Levetiracetam—Asthenia—Paclitaxel—kidney cancer	7.59e-05	0.000361	CcSEcCtD
Levetiracetam—Decreased appetite—Capecitabine—kidney cancer	7.55e-05	0.000359	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—kidney cancer	7.51e-05	0.000357	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Capecitabine—kidney cancer	7.5e-05	0.000356	CcSEcCtD
Levetiracetam—Fatigue—Capecitabine—kidney cancer	7.49e-05	0.000356	CcSEcCtD
Levetiracetam—Pruritus—Paclitaxel—kidney cancer	7.49e-05	0.000356	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—kidney cancer	7.45e-05	0.000354	CcSEcCtD
Levetiracetam—Constipation—Capecitabine—kidney cancer	7.43e-05	0.000353	CcSEcCtD
Levetiracetam—Pain—Capecitabine—kidney cancer	7.43e-05	0.000353	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—kidney cancer	7.36e-05	0.00035	CcSEcCtD
Levetiracetam—Diarrhoea—Paclitaxel—kidney cancer	7.24e-05	0.000344	CcSEcCtD
Levetiracetam—Feeling abnormal—Capecitabine—kidney cancer	7.16e-05	0.00034	CcSEcCtD
Levetiracetam—ABCC2—Irinotecan Pathway—APC—kidney cancer	7.13e-05	0.0237	CbGpPWpGaD
Levetiracetam—Immune system disorder—Doxorubicin—kidney cancer	7.12e-05	0.000338	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Capecitabine—kidney cancer	7.1e-05	0.000337	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—kidney cancer	7.1e-05	0.000337	CcSEcCtD
Levetiracetam—Dizziness—Paclitaxel—kidney cancer	7e-05	0.000333	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—kidney cancer	6.96e-05	0.000331	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—KCNMA1—kidney cancer	6.93e-05	0.023	CbGpPWpGaD
Levetiracetam—Mental disorder—Doxorubicin—kidney cancer	6.9e-05	0.000328	CcSEcCtD
Levetiracetam—Abdominal pain—Capecitabine—kidney cancer	6.87e-05	0.000326	CcSEcCtD
Levetiracetam—Body temperature increased—Capecitabine—kidney cancer	6.87e-05	0.000326	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—kidney cancer	6.86e-05	0.000326	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—kidney cancer	6.73e-05	0.00032	CcSEcCtD
Levetiracetam—Vomiting—Paclitaxel—kidney cancer	6.73e-05	0.00032	CcSEcCtD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—ACHE—kidney cancer	6.69e-05	0.0222	CbGpPWpGaD
Levetiracetam—Rash—Paclitaxel—kidney cancer	6.67e-05	0.000317	CcSEcCtD
Levetiracetam—Dermatitis—Paclitaxel—kidney cancer	6.67e-05	0.000317	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—kidney cancer	6.66e-05	0.000317	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—kidney cancer	6.63e-05	0.000315	CcSEcCtD
Levetiracetam—Headache—Paclitaxel—kidney cancer	6.63e-05	0.000315	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—kidney cancer	6.46e-05	0.000307	CcSEcCtD
Levetiracetam—Hypersensitivity—Capecitabine—kidney cancer	6.4e-05	0.000304	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—kidney cancer	6.3e-05	0.0003	CcSEcCtD
Levetiracetam—Nausea—Paclitaxel—kidney cancer	6.29e-05	0.000299	CcSEcCtD
Levetiracetam—Asthenia—Capecitabine—kidney cancer	6.23e-05	0.000296	CcSEcCtD
Levetiracetam—SV2A—Disease—CCBL1—kidney cancer	6.2e-05	0.0206	CbGpPWpGaD
Levetiracetam—Vertigo—Doxorubicin—kidney cancer	6.16e-05	0.000293	CcSEcCtD
Levetiracetam—Pruritus—Capecitabine—kidney cancer	6.14e-05	0.000292	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—kidney cancer	6.14e-05	0.000292	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—kidney cancer	5.99e-05	0.000284	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—kidney cancer	5.94e-05	0.000282	CcSEcCtD
Levetiracetam—Diarrhoea—Capecitabine—kidney cancer	5.94e-05	0.000282	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—kidney cancer	5.84e-05	0.000277	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—kidney cancer	5.84e-05	0.000277	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—kidney cancer	5.84e-05	0.000277	CcSEcCtD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BCHE—kidney cancer	5.83e-05	0.0194	CbGpPWpGaD
Levetiracetam—Anxiety—Doxorubicin—kidney cancer	5.82e-05	0.000277	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.8e-05	0.000276	CcSEcCtD
Levetiracetam—Dizziness—Capecitabine—kidney cancer	5.74e-05	0.000273	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—kidney cancer	5.64e-05	0.000268	CcSEcCtD
Levetiracetam—SV2A—Disease—AMER1—kidney cancer	5.61e-05	0.0186	CbGpPWpGaD
Levetiracetam—Infection—Doxorubicin—kidney cancer	5.56e-05	0.000264	CcSEcCtD
Levetiracetam—Vomiting—Capecitabine—kidney cancer	5.52e-05	0.000262	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—HARS—kidney cancer	5.52e-05	0.0183	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Doxorubicin—kidney cancer	5.49e-05	0.000261	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—kidney cancer	5.48e-05	0.00026	CcSEcCtD
Levetiracetam—Rash—Capecitabine—kidney cancer	5.48e-05	0.00026	CcSEcCtD
Levetiracetam—Dermatitis—Capecitabine—kidney cancer	5.47e-05	0.00026	CcSEcCtD
Levetiracetam—Headache—Capecitabine—kidney cancer	5.44e-05	0.000259	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—kidney cancer	5.44e-05	0.000258	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—kidney cancer	5.34e-05	0.000254	CcSEcCtD
Levetiracetam—Nausea—Capecitabine—kidney cancer	5.16e-05	0.000245	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—ACHE—kidney cancer	5.13e-05	0.017	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	5.11e-05	0.017	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.1e-05	0.000242	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—kidney cancer	5.06e-05	0.000241	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—kidney cancer	5.03e-05	0.000239	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—kidney cancer	4.98e-05	0.000236	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—kidney cancer	4.93e-05	0.000234	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—kidney cancer	4.87e-05	0.000231	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	4.87e-05	0.0162	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.83e-05	0.00023	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—kidney cancer	4.83e-05	0.000229	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—kidney cancer	4.79e-05	0.000227	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—kidney cancer	4.79e-05	0.000227	CcSEcCtD
Levetiracetam—SV2A—Disease—GPC3—kidney cancer	4.7e-05	0.0156	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB1—kidney cancer	4.65e-05	0.0154	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Doxorubicin—kidney cancer	4.61e-05	0.000219	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—kidney cancer	4.58e-05	0.000218	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—BCHE—kidney cancer	4.47e-05	0.0148	CbGpPWpGaD
Levetiracetam—Abdominal pain—Doxorubicin—kidney cancer	4.43e-05	0.00021	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—kidney cancer	4.43e-05	0.00021	CcSEcCtD
Levetiracetam—SV2A—Disease—ST3GAL2—kidney cancer	4.35e-05	0.0144	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Doxorubicin—kidney cancer	4.12e-05	0.000196	CcSEcCtD
Levetiracetam—SV2A—Disease—PGK1—kidney cancer	4.07e-05	0.0135	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC5A3—kidney cancer	4.07e-05	0.0135	CbGpPWpGaD
Levetiracetam—Asthenia—Doxorubicin—kidney cancer	4.02e-05	0.000191	CcSEcCtD
Levetiracetam—SV2A—Disease—LDHB—kidney cancer	3.99e-05	0.0133	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SFRP2—kidney cancer	3.99e-05	0.0133	CbGpPWpGaD
Levetiracetam—Pruritus—Doxorubicin—kidney cancer	3.96e-05	0.000188	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—kidney cancer	3.83e-05	0.000182	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—SLC5A3—kidney cancer	3.77e-05	0.0125	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TCEB1—kidney cancer	3.73e-05	0.0124	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TCEB2—kidney cancer	3.73e-05	0.0124	CbGpPWpGaD
Levetiracetam—Dizziness—Doxorubicin—kidney cancer	3.7e-05	0.000176	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—kidney cancer	3.56e-05	0.000169	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—kidney cancer	3.53e-05	0.000168	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—kidney cancer	3.53e-05	0.000168	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—kidney cancer	3.51e-05	0.000167	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	3.35e-05	0.0111	CbGpPWpGaD
Levetiracetam—Nausea—Doxorubicin—kidney cancer	3.33e-05	0.000158	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—KEAP1—kidney cancer	3.3e-05	0.0109	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—LRRK2—kidney cancer	3.17e-05	0.0105	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	3.11e-05	0.0103	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RPL14—kidney cancer	3.03e-05	0.0101	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BRAF—kidney cancer	2.98e-05	0.00988	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	2.85e-05	0.00945	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ITPR2—kidney cancer	2.74e-05	0.00909	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—RAF1—kidney cancer	2.49e-05	0.00825	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	2.32e-05	0.00769	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PSMD7—kidney cancer	2.29e-05	0.00762	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—BRAF—kidney cancer	2.28e-05	0.00757	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	2.1e-05	0.00698	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A1—kidney cancer	2.07e-05	0.00689	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JUNB—kidney cancer	2.06e-05	0.00684	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	1.99e-05	0.0066	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	1.92e-05	0.00638	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—RAF1—kidney cancer	1.9e-05	0.00632	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL13—kidney cancer	1.81e-05	0.006	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—EGR1—kidney cancer	1.78e-05	0.00592	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.7e-05	0.00566	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	1.7e-05	0.00566	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN2B—kidney cancer	1.68e-05	0.00557	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTP1—kidney cancer	1.6e-05	0.00532	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—kidney cancer	1.47e-05	0.00489	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIF1A—kidney cancer	1.34e-05	0.00445	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TSC2—kidney cancer	1.34e-05	0.00444	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—MAPK1—kidney cancer	1.31e-05	0.00434	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	1.23e-05	0.00409	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.21e-05	0.00401	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.21e-05	0.00401	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.21e-05	0.00401	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KIT—kidney cancer	1.18e-05	0.00392	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APC—kidney cancer	1.18e-05	0.00392	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BRAF—kidney cancer	1.11e-05	0.00369	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	1.1e-05	0.00366	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	1.06e-05	0.00353	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	1.06e-05	0.00353	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	1.01e-05	0.00335	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	9.89e-06	0.00328	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RAF1—kidney cancer	9.27e-06	0.00308	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERBB2—kidney cancer	9.17e-06	0.00304	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTOR—kidney cancer	9.05e-06	0.003	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD4—kidney cancer	9.03e-06	0.003	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—kidney cancer	8.97e-06	0.00298	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	8.85e-06	0.00294	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	8.76e-06	0.00291	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN1B—kidney cancer	8.49e-06	0.00282	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	8.05e-06	0.00267	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CTNNB1—kidney cancer	8.02e-06	0.00266	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—kidney cancer	7.82e-06	0.0026	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	7.23e-06	0.0024	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	7.23e-06	0.0024	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	6.77e-06	0.00225	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.76e-06	0.00225	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK3—kidney cancer	6.68e-06	0.00222	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	6.64e-06	0.0022	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—kidney cancer	6.5e-06	0.00216	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.37e-06	0.00211	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK1—kidney cancer	6.36e-06	0.00211	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.15e-06	0.00204	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—kidney cancer	6e-06	0.00199	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.94e-06	0.00197	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—kidney cancer	5.91e-06	0.00196	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.89e-06	0.00195	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	5.8e-06	0.00193	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.68e-06	0.00189	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.68e-06	0.00189	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.68e-06	0.00189	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CA—kidney cancer	5.52e-06	0.00183	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACY1—kidney cancer	5.06e-06	0.00168	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—kidney cancer	5.02e-06	0.00167	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.86e-06	0.00161	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PDHB—kidney cancer	4.3e-06	0.00143	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.15e-06	0.00138	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CCBL1—kidney cancer	4.05e-06	0.00134	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GLIPR1—kidney cancer	3.51e-06	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPAT—kidney cancer	3.51e-06	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APRT—kidney cancer	3.26e-06	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FH—kidney cancer	3.26e-06	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.25e-06	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.22e-06	0.00107	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.15e-06	0.00105	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPC3—kidney cancer	3.07e-06	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.99e-06	0.000994	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA2—kidney cancer	2.98e-06	0.000991	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.98e-06	0.00099	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALAD—kidney cancer	2.91e-06	0.000965	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.89e-06	0.00096	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.84e-06	0.000944	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.84e-06	0.000942	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.84e-06	0.000942	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.82e-06	0.000935	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.77e-06	0.000921	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.75e-06	0.000912	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.74e-06	0.000911	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A3—kidney cancer	2.66e-06	0.000883	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PGK1—kidney cancer	2.66e-06	0.000883	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LDHB—kidney cancer	2.61e-06	0.000866	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.48e-06	0.000823	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.35e-06	0.000779	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.28e-06	0.000757	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA9—kidney cancer	2.26e-06	0.000751	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.23e-06	0.000741	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.11e-06	0.0007	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.94e-06	0.000643	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CRABP1—kidney cancer	1.92e-06	0.000638	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.87e-06	0.000622	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ITPR2—kidney cancer	1.79e-06	0.000593	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—kidney cancer	1.63e-06	0.000541	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACHE—kidney cancer	1.63e-06	0.000541	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SCARB1—kidney cancer	1.54e-06	0.000512	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS1—kidney cancer	1.53e-06	0.000507	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PSMD7—kidney cancer	1.5e-06	0.000497	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BCHE—kidney cancer	1.42e-06	0.000471	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A5—kidney cancer	1.4e-06	0.000466	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A1—kidney cancer	1.35e-06	0.00045	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.29e-06	0.000429	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—kidney cancer	1.13e-06	0.000375	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—kidney cancer	1.04e-06	0.000345	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A1—kidney cancer	9.84e-07	0.000327	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—POMC—kidney cancer	7.34e-07	0.000244	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—kidney cancer	5.85e-07	0.000194	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—kidney cancer	5.1e-07	0.000169	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—kidney cancer	3.6e-07	0.00012	CbGpPWpGaD
